AstraZeneca Pharma India receives CDSCO approval for tumour-agnostic use of Trastuzumab Deruxtecan
New indication approved for treatment of unresectable or metastatic HER2-positive solid tumours in adult patients after prior…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin launches generic Liraglutide Injection in the U.S. market
New launch offers bioequivalent alternative to Victoza for type 2 diabetes management in adults and children aged 10 and above
FDA launches pilot program to prioritise review of U.S. made generic drug applications
New initiative offers faster ANDA reviews for companies using domestic manufacturing and testing to bolster U.S. pharma supply…
IPA announces leadership transition
Sharvil Patel, MD, Zydus Lifesciences and former VP, IPA, assumes the role of President,; Glenn Saldanha, Chairman and MD,…
Supriya Lifescience receives WHO GMP Certification for Ambernath Facility
Approval enables commercial production of formulations with projected revenue potential of ₹500 crore
AI compass: Transforming pharma commercialisation
As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…
Understanding real-world microbiological outcomes will guide long-term CFTR modulator use in CF:…
Real-world microbiological data reveal complex trends in CFTR modulator therapy, highlighting the need for tailored long-term…
Driving India’s innovation edge
Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma…
Panel Discussion: Moving up the value chain without losing volume advantage
India has earned global recognition for making affordable medicines available at scale. But the big question now is: can India…
Next-gen CDMOs: What will they look like
Dr Huzaifa S Choonia, Director & Head, Drug Substance-MSAT, OneSource, spoke on how next generation contract development and…